Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.06 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.89.
Market Cap
9.06T
Revenue
4.67T
Profits
189.18B
PE Ratio
47.89
Profit Margin
4.05%
Dividend Yield
0.39%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 994.49B | -0.65% | 1,838,398 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 640.02B | -0.29% | 4,706,292 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 454.36B | 0.83% | 4,308,856 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 355.10B | -0.54% | 8,679,443 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 340.27B | -2.37% | 7,484,666 | 450.53B |
| 6 | NVS | Novartis AG | 261.03B | -0.23% | 2,353,808 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 245.58B | 0.33% | 2,229,337 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 225.48B | 1.10% | 1,786,983 | 46.34B |
| 9 | AMGN | Amgen Inc. | 204.01B | -1.34% | 2,272,874 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 189.82B | -2.14% | 11,029,063 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 178.21B | -0.75% | 4,202,447 | 30.46B |
| 12 | ABT | Abbott Laboratories | 176.41B | -1.36% | 8,398,312 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.99B | 0.25% | 25,557,178 | 63.70B |
| 14 | DHR | Danaher Corporation | 140.70B | -0.19% | 3,628,491 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 130.64B | 0.17% | 875,636 | 12.59B |
| 16 | ISRG | Intuitive Surgical, Inc. | 130.41B | 2.41% | 3,351,569 | 11.03B |
| 17 | BMY | Bristol-Myers Squibb Company | 130.00B | -0.17% | 7,055,796 | 49.19B |
| 18 | CVS | CVS Health Corporation | 121.07B | -0.66% | 4,380,268 | 412.65B |
| 19 | MDT | Medtronic plc | 116.35B | -0.72% | 5,408,613 | 37.54B |
| 20 | SYK | Stryker Corporation | 105.70B | 2.06% | 3,724,209 | 25.84B |
| 21 | MCK | McKesson Corporation | 102.78B | 0.07% | 888,805 | 410.98B |
| 22 | SNY | Sanofi | 101.87B | 0.12% | 2,373,014 | 55.89B |
| 23 | GSK | GSK plc | 95.94B | 0.02% | 2,276,994 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.43B | 1.36% | 1,321,396 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 90.81B | 0.52% | 1,359,466 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.04B | -1.48% | 443,987 | 15.53B |
| 27 | CI | The Cigna Group | 74.19B | -0.05% | 1,342,128 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 62.29B | -0.28% | 26,986,790 | 21.00B |
| 29 | ARGX | argenx SE | 61.97B | 0.04% | 181,875 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.36B | 0.19% | 844,057 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.65B | 0.83% | 2,150,013 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 57.48B | 5.38% | 15,409,298 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.56B | -0.61% | 1,111,693 | 254.25B |
| 34 | HUM | Humana Inc. | 49.21B | 2.26% | 684,064 | 145.68B |
| 35 | EW | Edwards Lifesciences Corporation | 48.63B | -2.77% | 3,795,193 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 48.44B | 0.81% | 1,584,104 | 22.48B |
| 37 | NTRA | Natera, Inc. | 47.41B | 0.86% | 798,060 | 2.71B |
| 38 | RVMD | Revolution Medicines, Inc. | 43.68B | 0.21% | 1,378,679 | - |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 43.22B | 2.04% | 2,855,423 | 17.32B |
| 40 | IQV | IQVIA Holdings Inc. | 43.09B | 1.74% | 1,428,623 | 16.98B |
| 41 | MDLN | Medline Inc. | 42.77B | 0.43% | 4,647,475 | 29.94B |
| 42 | VEEV | Veeva Systems Inc. | 42.48B | 0.54% | 863,803 | 3.46B |
| 43 | A | Agilent Technologies, Inc. | 41.42B | 2.66% | 1,775,725 | 7.37B |
| 44 | WAT | Waters Corporation | 40.12B | 1.67% | 487,177 | 4.64B |
| 45 | HLN | Haleon plc | 39.76B | -0.33% | 10,035,732 | 14.80B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 39.76B | -0.36% | 401,628 | 4.55B |
| 47 | ONC | BeOne Medicines AG | 39.40B | 1.38% | 307,784 | 6.13B |
| 48 | RPRX | Royalty Pharma plc | 33.70B | -0.24% | 2,596,056 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.28B | 0.47% | 1,177,421 | 4.80B |
| 50 | CNC | Centene Corporation | 32.81B | 1.56% | 3,631,127 | 180.30B |
| 51 | BIIB | Biogen Inc. | 32.08B | 0.80% | 1,075,556 | 10.03B |
| 52 | ALC | Alcon Inc. | 31.98B | -0.78% | 1,942,107 | 10.86B |
| 53 | DXCM | DexCom, Inc. | 31.33B | -1.75% | 2,547,398 | 4.97B |
| 54 | RMD | ResMed Inc. | 31.23B | -0.60% | 912,333 | 5.65B |
| 55 | ILMN | Illumina, Inc. | 31.17B | 2.57% | 2,412,437 | 4.49B |
| 56 | ZTS | Zoetis Inc. | 30.15B | 0.15% | 5,242,670 | 9.53B |
| 57 | ROIV | Roivant Sciences Ltd. | 29.49B | -0.29% | 5,963,910 | 7.53M |
| 58 | GEHC | GE HealthCare Technologies Inc. | 28.88B | -0.48% | 3,198,492 | 21.27B |
| 59 | INSM | Insmed Incorporated | 28.26B | 1.67% | 1,698,269 | 1.14B |
| 60 | DGX | Quest Diagnostics Incorporated | 25.94B | 1.68% | 997,025 | 11.56B |
| 61 | MTD | Mettler-Toledo International Inc. | 25.92B | 1.01% | 96,703 | 4.13B |
| 62 | LH | Labcorp Holdings Inc. | 25.27B | 1.49% | 809,931 | 14.35B |
| 63 | INCY | Incyte Corporation | 24.62B | -1.47% | 1,425,199 | 5.82B |
| 64 | WST | West Pharmaceutical Services, Inc. | 24.37B | 0.58% | 541,791 | 3.33B |
| 65 | BNTX | BioNTech SE | 24.30B | 0.34% | 1,176,646 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 23.98B | -0.04% | 765,406 | 20.18B |
| 67 | UTHR | United Therapeutics Corporation | 21.32B | -1.34% | 573,361 | 3.15B |
| 68 | THC | Tenet Healthcare Corporation | 21.23B | 0.09% | 588,088 | 21.81B |
| 69 | GH | Guardant Health, Inc. | 21.12B | -1.04% | 695,946 | 1.18B |
| 70 | STE | STERIS plc | 20.55B | -0.80% | 595,421 | 6.04B |
| 71 | GMAB | Genmab A/S | 19.41B | 0.74% | 1,394,021 | 4.13B |
| 72 | VTRS | Viatris Inc. | 18.96B | 0.79% | 12,174,065 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.83B | 1.14% | 1,876,546 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.31B | 0.87% | 443,605 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.40B | 0.75% | 159,087 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.96B | 2.21% | 422,911 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.88B | -0.22% | 890,877 | 3.37B |
| 78 | SOLV | Solventum Corporation | 14.89B | -0.23% | 774,433 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.16B | -0.08% | 1,766,613 | 713.07M |
| 80 | SMMT | Summit Therapeutics Inc. | 14.00B | 3.24% | 4,278,138 | - |
| 81 | EXEL | Exelixis, Inc. | 13.91B | -2.28% | 2,916,864 | 2.44B |
| 82 | RVTY | Revvity, Inc. | 13.87B | 2.79% | 1,151,505 | 2.91B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.28B | 1.93% | 767,561 | 4.00B |
| 84 | ICLR | ICON Public Limited Company | 13.06B | 2.18% | 1,710,006 | 8.29B |
| 85 | BMRN | BioMarin Pharmaceutical Inc. | 12.71B | 0.26% | 1,604,795 | 3.41B |
| 86 | PEN | Penumbra, Inc. | 12.52B | -0.02% | 152,618 | 1.50B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.35B | 0.26% | 187,643 | 1.28B |
| 88 | BAX | Baxter International Inc. | 12.30B | -1.57% | 5,450,645 | 11.47B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.23B | 1.47% | 2,489,938 | 14.37B |
| 90 | CORT | Corcept Therapeutics Incorporated | 12.19B | -1.85% | 1,282,453 | 830.81M |
| 91 | HALO | Halozyme Therapeutics, Inc. | 12.17B | 0.19% | 861,582 | 1.66B |
| 92 | EHC | Encompass Health Corporation | 12.01B | 0.55% | 649,324 | 6.21B |
| 93 | FMS | Fresenius Medical Care AG | 11.82B | 0.54% | 584,829 | 22.19B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.70B | 0.11% | 1,335,818 | 669.50M |
| 95 | DVA | DaVita Inc. | 11.58B | 0.12% | 767,847 | 14.01B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.58B | 1.36% | 4,738,375 | 5.02B |
| 97 | AXSM | Axsome Therapeutics, Inc. | 11.56B | 4.56% | 1,228,407 | 776.57M |
| 98 | SNN | Smith & Nephew plc | 11.47B | -0.43% | 1,140,429 | 6.30B |
| 99 | TECH | Bio-Techne Corporation | 11.31B | 0.06% | 2,723,696 | 1.22B |
| 100 | ALGN | Align Technology, Inc. | 10.71B | 0.07% | 619,849 | 4.14B |
| 101 | TEM | Tempus AI, Inc. | 10.65B | 0.46% | 3,690,132 | 1.43B |
| 102 | MOH | Molina Healthcare, Inc. | 10.64B | 1.97% | 502,987 | 42.47B |
| 103 | KRSA | Korsana Biosciences, Inc. | 10.32B | 29.91% | 114,120 | - |
| 104 | UHS | Universal Health Services, Inc. | 10.30B | 1.22% | 519,031 | 18.11B |
| 105 | KRYS | Krystal Biotech, Inc. | 10.27B | 0.42% | 206,324 | 440.48M |
| 106 | CYTK | Cytokinetics, Incorporated | 10.26B | 0.20% | 1,721,519 | 67.67M |
| 107 | COO | The Cooper Companies, Inc. | 10.25B | -0.48% | 6,439,686 | 4.24B |
| 108 | ABVX | ABIVAX Société Anonyme | 10.25B | 2.32% | 893,453 | 5.67M |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.12B | 1.62% | 3,143,774 | 3.50B |
| 110 | OSCR | Oscar Health, Inc. | 10.10B | 0.58% | 7,100,690 | 15.32B |
| 111 | ENSG | The Ensign Group, Inc. | 10.05B | 0.69% | 318,954 | 5.49B |
| 112 | AVTR | Avantor, Inc. | 10.02B | -0.47% | 6,179,065 | 6.56B |
| 113 | GMED | Globus Medical, Inc. | 9.96B | 0.86% | 1,486,444 | 3.14B |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 9.87B | 0.15% | 344,834 | 2.59B |
| 115 | GKOS | Glaukos Corporation | 9.86B | -1.84% | 552,413 | 612.84M |
| 116 | HSIC | Henry Schein, Inc. | 9.85B | 1.21% | 713,850 | 13.60B |
| 117 | PTGX | Protagonist Therapeutics, Inc. | 9.59B | 2.08% | 478,038 | 281.99M |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.56B | -1.74% | 574,186 | 105.00M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 9.34B | -1.18% | 175,410 | 7.46M |
| 120 | RGEN | Repligen Corporation | 9.32B | 0.30% | 944,559 | 785.10M |
| 121 | PODD | Insulet Corporation | 9.15B | -2.02% | 1,747,978 | 3.05B |
| 122 | IONS | Ionis Pharmaceuticals, Inc. | 9.01B | -2.59% | 2,175,779 | 874.09M |
| 123 | TXG | 10x Genomics, Inc. | 8.94B | 3.33% | 1,829,697 | 616.91M |
| 124 | PCVX | Vaxcyte, Inc. | 8.85B | 0.97% | 1,683,431 | - |
| 125 | QGEN | Qiagen N.V. | 8.79B | 0.88% | 1,107,756 | 2.10B |
| 126 | IBRX | ImmunityBio, Inc. | 8.38B | 2.46% | 12,468,768 | 165.79M |
| 127 | BRKR | Bruker Corporation | 8.14B | -0.24% | 2,091,333 | 3.50B |
| 128 | SYRE | Spyre Therapeutics, Inc. | 7.99B | 2.13% | 886,055 | - |
| 129 | TWST | Twist Bioscience Corporation | 7.98B | 0.29% | 1,108,726 | 431.80M |
| 130 | HQY | HealthEquity, Inc. | 7.96B | 1.81% | 652,361 | 1.36B |
| 131 | ATR | AptarGroup, Inc. | 7.94B | 1.45% | 491,927 | 3.93B |
| 132 | IMVT | Immunovant, Inc. | 7.72B | -1.94% | 1,031,890 | - |
| 133 | ALKS | Alkermes plc | 7.71B | -0.30% | 1,283,128 | 1.67B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.64B | -2.71% | 1,368,582 | 799.54M |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.21B | 2.46% | 573,722 | 239.92M |
| 136 | HNGE | Hinge Health, Inc. | 7.15B | 0.37% | 1,726,551 | 720.06M |
| 137 | PACS | PACS Group, Inc. | 7.09B | -0.20% | 627,997 | 5.55B |
| 138 | BLTE | Belite Bio, Inc | 7.00B | -0.73% | 154,554 | - |
| 139 | CAI | Caris Life Sciences, Inc. | 6.88B | 1.25% | 1,822,971 | 989.61M |
| 140 | GRFS | Grifols, S.A. | 6.80B | -1.31% | 513,348 | 8.48B |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.75B | -0.47% | 994,405 | - |
| 142 | CHE | Chemed Corporation | 6.72B | 0.31% | 81,825 | 2.60B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.14% | 1,208,993 | 1.56B |
| 144 | HIMS | Hims & Hers Health, Inc. | 6.42B | 0.26% | 7,091,482 | 2.58B |
| 145 | CGON | CG Oncology, Inc. | 6.41B | 0.49% | 759,836 | 6.23M |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.38B | -2.38% | 441,100 | 618.07M |
| 147 | MMED | MiniMed Group, Inc. | 6.33B | 0.27% | 1,423,592 | 3.22B |
| 148 | TVTX | Travere Therapeutics, Inc. | 6.24B | -1.98% | 1,149,770 | 591.33M |
| 149 | BLCO | Bausch + Lomb Corporation | 6.16B | -1.71% | 460,178 | 5.32B |
| 150 | ORKA | Oruka Therapeutics, Inc. | 6.12B | 0.80% | 585,302 | - |
| 151 | LQDA | Liquidia Corporation | 5.97B | -1.64% | 778,799 | 450.91M |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.95B | -0.27% | 576,562 | 840.85M |
| 153 | RDNT | RadNet, Inc. | 5.94B | 1.63% | 610,328 | 2.27B |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 5.94B | 2.83% | 732,764 | 1.90M |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.92B | 0.83% | 1,157,718 | 3.12B |
| 156 | COGT | Cogent Biosciences, Inc. | 5.80B | -1.97% | 1,715,802 | - |
| 157 | STVN | Stevanato Group S.p.A. | 5.71B | -0.24% | 885,738 | 1.40B |
| 158 | XENE | Xenon Pharmaceuticals Inc. | 5.68B | -0.26% | 466,755 | 7.50M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 5.67B | -1.65% | 261,167 | 290.54M |
| 160 | ERAS | Erasca, Inc. | 5.55B | -0.94% | 2,883,857 | - |
| 161 | TFX | Teleflex Incorporated | 5.55B | -0.77% | 572,746 | 2.25B |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.51B | -1.94% | 792,890 | 1.01B |
| 163 | SHC | Sotera Health Company | 5.24B | 0.60% | 1,308,044 | 1.22B |
| 164 | DFTX | Definium Therapeutics, Inc. | 5.23B | 3.07% | 1,754,315 | - |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.16B | -0.13% | 443,186 | 1.58B |
| 166 | CRSP | CRISPR Therapeutics AG | 5.00B | -1.03% | 856,711 | 13.39M |
| 167 | LFST | LifeStance Health Group, Inc. | 4.96B | -0.23% | 7,055,617 | 1.58B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.82B | 3.50% | 1,404,272 | - |
| 169 | ACAD | ACADIA Pharmaceuticals Inc. | 4.80B | 0.32% | 1,172,903 | 1.14B |
| 170 | HAE | Haemonetics Corporation | 4.67B | 1.61% | 458,309 | 1.35B |
| 171 | BLLN | BillionToOne, Inc. | 4.66B | 0.26% | 406,055 | 397.41M |
| 172 | DOCS | Doximity, Inc. | 4.56B | 3.52% | 2,696,119 | 655.57M |
| 173 | PBLS | Parabilis Medicines, Inc. | 4.56B | 1.54% | 364,815 | 148.00K |
| 174 | WAY | Waystar Holding Corp. | 4.50B | 1.78% | 1,731,361 | 1.21B |
| 175 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | 2.07% | 655,273 | 2.29B |
| 176 | HTFL | HeartFlow, Inc. | 4.34B | 9.65% | 2,215,986 | 212.07M |
| 177 | LIVN | LivaNova PLC | 4.31B | - | 552,416 | 1.47B |
| 178 | ITGR | Integer Holdings Corporation | 4.28B | -0.04% | 449,897 | 1.84B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.14B | -0.11% | 4,164,383 | 10.35M |
| 180 | MANE | Veradermics, Incorporated | 4.13B | 0.85% | 576,028 | - |
| 181 | NVST | Envista Holdings Corporation | 4.10B | -1.24% | 3,987,655 | 2.86B |
| 182 | CELC | Celcuity Inc. | 4.08B | -2.39% | 863,370 | - |
| 183 | INDV | Indivior Pharmaceuticals, Inc. | 4.07B | -0.06% | 1,297,261 | 1.33B |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.01B | 1.75% | 2,279,286 | 53.81M |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.98B | -5.13% | 415,338 | 890.79M |
| 186 | ELVN | Enliven Therapeutics, Inc. | 3.98B | -3.40% | 995,817 | - |
| 187 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.97B | -1.46% | 1,712,745 | -665.00K |
| 188 | ICUI | ICU Medical, Inc. | 3.91B | -0.50% | 189,017 | 2.16B |
| 189 | IOVA | Iovance Biotherapeutics, Inc. | 3.90B | 5.65% | 12,388,719 | 324.97M |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.86B | -0.12% | 1,238,269 | 308.08M |
| 191 | PLSE | Pulse Biosciences, Inc. | 3.79B | -2.43% | 664,329 | 1.19M |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.73B | -0.47% | 2,207,194 | - |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.67B | -1.28% | 524,568 | 825.34M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.63B | 0.37% | 429,248 | 234.13M |
| 195 | LEGN | Legend Biotech Corporation | 3.61B | -2.87% | 4,279,420 | 1.27B |
| 196 | OGN | Organon & Co. | 3.58B | 0.07% | 1,728,230 | 6.13B |
| 197 | ABCL | AbCellera Biologics Inc. | 3.53B | 4.11% | 4,378,323 | 66.17M |
| 198 | OPCH | Option Care Health, Inc. | 3.52B | -0.63% | 1,726,503 | 5.69B |
| 199 | NHC | National HealthCare Corporation | 3.52B | -0.20% | 51,958 | 1.56B |
| 200 | TARS | Tarsus Pharmaceuticals, Inc. | 3.48B | -2.23% | 490,787 | 606.33M |
| 201 | GRAL | GRAIL, Inc. | 3.40B | -1.71% | 360,986 | 165.26M |
| 202 | DYN | Dyne Therapeutics, Inc. | 3.40B | -1.14% | 3,774,441 | - |
| 203 | DNLI | Denali Therapeutics Inc. | 3.37B | -1.45% | 1,239,511 | 3.60M |
| 204 | VCYT | Veracyte, Inc. | 3.29B | -2.76% | 1,001,620 | 561.90M |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.13B | -5.97% | 4,277,166 | 117.00M |
| 206 | QURE | uniQure N.V. | 3.09B | 0.09% | 1,241,784 | 18.67M |
| 207 | AVAH | Aveanna Healthcare Holdings Inc. | 3.07B | 1.59% | 2,372,382 | 2.60B |
| 208 | WRBY | Warby Parker Inc. | 3.05B | 1.69% | 2,011,899 | 911.61M |
| 209 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | 2.16% | 2,044,715 | 463.98M |
| 210 | BKD | Brookdale Senior Living Inc. | 2.90B | -0.49% | 5,580,634 | 2.93B |
| 211 | CLDX | Celldex Therapeutics, Inc. | 2.90B | -3.15% | 1,033,541 | 158.00K |
| 212 | TMDX | TransMedics Group, Inc. | 2.85B | -3.36% | 1,247,318 | 668.47M |
| 213 | MBX | MBX Biosciences, Inc. | 2.84B | -3.15% | 306,208 | - |
| 214 | IMNM | Immunome, Inc. | 2.80B | -1.20% | 692,564 | 4.02M |
| 215 | RGC | Regencell Bioscience Holdings Limited | 2.79B | - | 102,327 | - |
| 216 | ATRC | AtriCure, Inc. | 2.77B | 2.98% | 1,098,948 | 569.62M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.76B | -0.43% | 923,195 | 1.46B |
| 218 | GPCR | Structure Therapeutics Inc. | 2.76B | -2.25% | 1,276,359 | - |
| 219 | NAMS | NewAmsterdam Pharma Company N.V. | 2.73B | 4.30% | 1,596,533 | 7.12M |
| 220 | ZLAB | Zai Lab Limited | 2.71B | -0.12% | 663,515 | 449.61M |
| 221 | IRON | Disc Medicine, Inc. | 2.69B | -5.50% | 628,948 | - |
| 222 | PHVS | Pharvaris N.V. | 2.67B | 1.36% | 1,449,491 | - |
| 223 | ACHC | Acadia Healthcare Company, Inc. | 2.64B | -0.60% | 653,209 | 3.37B |
| 224 | ALHC | Alignment Healthcare, Inc. | 2.62B | -1.18% | 6,076,709 | 4.58B |
| 225 | PRVA | Privia Health Group, Inc. | 2.61B | 0.25% | 925,300 | 2.36B |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.60B | -2.75% | 1,321,662 | 36.77M |
| 227 | CDNA | CareDx, Inc. | 2.60B | 0.48% | 663,052 | 458.09M |
| 228 | NEOG | Neogen Corporation | 2.57B | 0.08% | 1,666,258 | 870.40M |
| 229 | CLOV | Clover Health Investments, Corp. | 2.56B | 2.34% | 4,491,712 | 2.48B |
| 230 | WGS | GeneDx Holdings Corp. | 2.54B | 1.55% | 331,597 | 454.43M |
| 231 | VERA | Vera Therapeutics, Inc. | 2.53B | 4.32% | 3,796,747 | - |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.49B | -3.75% | 1,729,438 | - |
| 233 | AXGN | Axogen, Inc. | 2.47B | 0.74% | 3,477,623 | 251.17M |
| 234 | PGEN | Precigen, Inc. | 2.45B | 2.54% | 2,061,201 | 85.72M |
| 235 | SUPN | Supernus Pharmaceuticals, Inc. | 2.42B | -0.12% | 707,160 | 830.44M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | 1.02% | 1,123,411 | 959.90M |
| 237 | VRDN | Viridian Therapeutics, Inc. | 2.41B | -4.71% | 944,077 | 71.13M |
| 238 | BEAM | Beam Therapeutics Inc. | 2.40B | -1.56% | 1,194,469 | 156.04M |
| 239 | NKTR | Nektar Therapeutics | 2.38B | -1.26% | 784,205 | 54.59M |
| 240 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | -14.42% | 14,709,891 | - |
| 241 | OCUL | Ocular Therapeutix, Inc. | 2.30B | -1.22% | 2,638,752 | 52.06M |
| 242 | TRVI | Trevi Therapeutics, Inc. | 2.27B | -0.06% | 2,016,067 | - |
| 243 | HCM | HUTCHMED (China) Limited | 2.26B | -2.29% | 82,747 | 549.12M |
| 244 | NEO | NeoGenomics, Inc. | 2.23B | -1.65% | 1,072,054 | 766.30M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.22B | -0.82% | 495,641 | 1.10B |
| 246 | BHC | Bausch Health Companies Inc. | 2.19B | -3.46% | 2,406,542 | 10.85B |
| 247 | TRLV | Trulieve Cannabis Corp. | 2.18B | -0.09% | 1,505,500 | 1.14B |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.16B | -0.17% | 163,366 | - |
| 249 | SRPT | Sarepta Therapeutics, Inc. | 2.16B | -0.34% | 1,810,737 | 1.97B |
| 250 | UFPT | UFP Technologies, Inc. | 2.15B | 0.18% | 83,847 | 631.64M |
| 251 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.06% | 745,441 | 311.51M |
| 252 | ADUS | Addus HomeCare Corporation | 2.14B | -1.21% | 130,607 | 1.48B |
| 253 | NUVB | Nuvation Bio Inc. | 2.13B | -3.34% | 4,318,563 | 169.90M |
| 254 | MD | Pediatrix Medical Group, Inc. | 2.12B | 0.15% | 516,909 | 1.95B |
| 255 | ESTA | Establishment Labs Holdings Inc. | 2.11B | -0.63% | 281,970 | 245.82M |
| 256 | INSP | Inspire Medical Systems, Inc. | 2.11B | 7.16% | 1,399,305 | 898.74M |
| 257 | PGNY | Progyny, Inc. | 2.10B | 1.00% | 1,244,648 | 1.31B |
| 258 | RAPP | Rapport Therapeutics, Inc. | 2.09B | 0.37% | 251,788 | 20.00M |
| 259 | XRAY | DENTSPLY SIRONA Inc. | 2.09B | -0.38% | 3,252,295 | 3.64B |
| 260 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.07B | -2.05% | 3,591,766 | 940.61M |
| 261 | URGN | UroGen Pharma Ltd. | 2.07B | 0.17% | 687,464 | 188.73M |
| 262 | ADMA | ADMA Biologics, Inc. | 2.07B | -1.70% | 2,266,782 | 512.28M |
| 263 | KOD | Kodiak Sciences Inc. | 2.06B | 0.06% | 682,568 | - |
| 264 | ZBIO | Zenas BioPharma, Inc. | 2.03B | 0.06% | 421,701 | 1.00M |
| 265 | GENB | Generate Biomedicines, Inc. | 2.02B | 2.14% | 666,179 | 26.48M |
| 266 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | -0.12% | 750,171 | 98.34M |
| 267 | MESO | Mesoblast Limited | 2.00B | -0.13% | 180,174 | 120.25M |
| 268 | CMPS | COMPASS Pathways plc | 1.99B | 0.91% | 2,015,599 | - |
| 269 | VCEL | Vericel Corporation | 1.96B | 1.24% | 503,531 | 306.30M |
| 270 | BFLY | Butterfly Network, Inc. | 1.95B | 2.95% | 3,423,696 | 112.14M |
| 271 | ASTH | Astrana Health, Inc. | 1.94B | -0.13% | 191,721 | 3.84B |
| 272 | ALMR | Alamar Biosciences, Inc. | 1.94B | 0.43% | 323,878 | 100.42M |
| 273 | BHVN | Biohaven Ltd. | 1.92B | -0.63% | 2,863,289 | - |
| 274 | PRGO | Perrigo Company plc | 1.90B | 0.52% | 1,828,693 | 4.14B |
| 275 | ALVO | Alvotech | 1.89B | 0.95% | 667,872 | 494.61M |
| 276 | STOK | Stoke Therapeutics, Inc. | 1.87B | -1.06% | 587,516 | 27.59M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.87B | -0.65% | 405,649 | 481.07M |
| 278 | GHRS | GH Research PLC | 1.87B | -0.29% | 159,249 | - |
| 279 | SGRY | Surgery Partners, Inc. | 1.87B | 1.84% | 1,287,953 | 3.37B |
| 280 | ZYME | Zymeworks Inc. | 1.86B | -0.76% | 1,030,812 | 37.13M |
| 281 | NBTX | Nanobiotix S.A. | 1.85B | -1.57% | 93,824 | 38.27M |
| 282 | LMAT | LeMaitre Vascular, Inc. | 1.84B | 2.27% | 278,953 | 262.43M |
| 283 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | -1.20% | 408,085 | - |
| 284 | XNCR | Xencor, Inc. | 1.81B | 0.62% | 905,274 | 104.97M |
| 285 | KLRA | Kailera Therapeutics, Inc. | 1.81B | -6.51% | 815,443 | - |
| 286 | NVCR | NovoCure Limited | 1.81B | 1.04% | 1,127,183 | 699.19M |
| 287 | SEPN | Septerna, Inc. | 1.80B | 2.01% | 354,801 | 98.88M |
| 288 | VIR | Vir Biotechnology, Inc. | 1.80B | 0.38% | 2,077,968 | 303.23M |
| 289 | LKFT | Lakefront Biotherapeutics NV | 1.76B | - | 245,821 | 1.13B |
| 290 | DMRA | Damora Therapeutics, Inc. | 1.73B | 4.69% | 525,411 | - |
| 291 | KARD | Kardigan, Inc. | 1.73B | -0.91% | 416,400 | - |
| 292 | PSNL | Personalis, Inc. | 1.73B | -0.73% | 1,407,019 | 69.67M |
| 293 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | 1.27% | 8,034,115 | 54.86M |
| 294 | BRVE | Braveheart Bio, Inc. | 1.71B | -2.24% | 283,592 | - |
| 295 | BLFS | BioLife Solutions, Inc. | 1.71B | 0.09% | 968,022 | 106.69M |
| 296 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -2.97% | 3,263,993 | 208.78M |
| 297 | IMCR | Immunocore Holdings plc | 1.68B | -2.92% | 313,505 | 430.78M |
| 298 | NTLA | Intellia Therapeutics, Inc. | 1.65B | -1.59% | 2,713,509 | 59.51M |
| 299 | FTRE | Fortrea Holdings Inc. | 1.64B | 1.06% | 1,427,609 | 2.68B |
| 300 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | -2.71% | 1,777,541 | 5.49M |
| 301 | ATEC | Alphatec Holdings, Inc. | 1.63B | 19.68% | 6,458,430 | 815.05M |
| 302 | ETON | Eton Pharmaceuticals, Inc. | 1.63B | -1.38% | 323,593 | 105.60M |
| 303 | SNDX | Syndax Pharmaceuticals, Inc. | 1.62B | -3.40% | 1,223,261 | 252.25M |
| 304 | INBX | Inhibrx Biosciences, Inc. | 1.61B | -1.93% | 211,017 | 1.30M |
| 305 | ANAB | AnaptysBio, Inc. | 1.60B | -2.34% | 336,187 | 232.39M |
| 306 | NVAX | Novavax, Inc. | 1.55B | 1.29% | 6,121,466 | 413.80M |
| 307 | ARDT | Ardent Health, Inc. | 1.55B | 0.73% | 349,554 | 6.41B |
| 308 | FRNM | Freenome, Inc. | 1.54B | -2.84% | 538,462 | 35.41M |
| 309 | BCAX | Bicara Therapeutics Inc. | 1.51B | -1.26% | 471,459 | - |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.51B | 0.64% | 548,825 | 1.86B |
| 311 | AGL | agilon health, inc. | 1.51B | -3.06% | 178,806 | 5.92B |
| 312 | ANIP | ANI Pharmaceuticals, Inc. | 1.50B | -1.78% | 371,405 | 978.38M |
| 313 | OMCL | Omnicell, Inc. | 1.50B | 1.67% | 483,646 | 1.25B |
| 314 | INVA | Innoviva, Inc. | 1.49B | 0.19% | 727,347 | 440.00M |
| 315 | AVLN | Avalyn Pharma Inc. | 1.49B | -3.17% | 132,884 | - |
| 316 | AAPG | Ascentage Pharma Group International | 1.47B | -3.42% | 7,145 | 94.61M |
| 317 | LTGO | Latigo Biotherapeutics, Inc. | 1.47B | 2.83% | 178,713 | - |
| 318 | INNV | InnovAge Holding Corp. | 1.47B | 1.42% | 192,102 | 989.71M |
| 319 | PAHC | Phibro Animal Health Corporation | 1.45B | -2.62% | 212,300 | 1.52B |
| 320 | LBRX | LB Pharmaceuticals Inc | 1.44B | -3.50% | 208,383 | - |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.43B | 1.05% | 1,131,972 | - |
| 322 | SDGR | Schrödinger, Inc. | 1.42B | 1.17% | 464,979 | 259.04M |
| 323 | ABSI | Absci Corporation | 1.41B | -0.36% | 1,966,428 | 1.56M |
| 324 | RARE | Ultragenyx Pharmaceutical Inc. | 1.41B | -0.69% | 3,253,693 | 717.00M |
| 325 | CNMD | CONMED Corporation | 1.39B | 0.17% | 237,567 | 1.37B |
| 326 | NUTX | Nutex Health Inc. | 1.37B | 2.58% | 137,036 | 846.72M |
| 327 | PNTG | The Pennant Group, Inc. | 1.37B | -0.25% | 299,065 | 1.10B |
| 328 | MAZE | Maze Therapeutics, Inc. | 1.37B | -0.89% | 1,052,241 | 20.00M |
| 329 | XERS | Xeris Biopharma Holdings, Inc. | 1.36B | -2.87% | 2,403,454 | 335.41M |
| 330 | AZTA | Azenta, Inc. | 1.35B | 2.22% | 748,608 | 613.81M |
| 331 | SVRA | Savara Inc. | 1.35B | -0.38% | 1,063,669 | - |
| 332 | KMTS | Kestra Medical Technologies, Ltd. | 1.34B | -3.05% | 241,992 | 95.13M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.33B | -0.07% | 410,398 | - |
| 334 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | -1.95% | 1,090,836 | - |
| 335 | OMER | Omeros Corporation | 1.32B | -1.67% | 1,014,308 | 38.42M |
| 336 | VOR | Vor Biopharma Inc. | 1.32B | -0.18% | 800,379 | - |
| 337 | TYRA | Tyra Biosciences, Inc. | 1.31B | -6.41% | 1,548,636 | - |
| 338 | TRAX | First Tracks Biotherapeutics, Inc. | 1.30B | -4.05% | 619,974 | - |
| 339 | AKTS | Aktis Oncology, Inc. | 1.30B | -2.67% | 228,578 | 10.06M |
| 340 | HROW | Harrow, Inc. | 1.29B | -5.74% | 987,695 | 275.59M |
| 341 | AMN | AMN Healthcare Services, Inc. | 1.29B | 0.88% | 480,440 | 3.43B |
| 342 | ANRO | Alto Neuroscience, Inc. | 1.26B | 1.01% | 415,745 | - |
| 343 | SPTX | Seaport Therapeutics, Inc. | 1.25B | 0.26% | 134,167 | - |
| 344 | ORIC | ORIC Pharmaceuticals, Inc. | 1.25B | -0.25% | 1,063,007 | - |
| 345 | MGTX | MeiraGTx Holdings plc | 1.23B | -0.47% | 459,550 | 397.50M |
| 346 | AORT | Artivion, Inc. | 1.22B | 1.74% | 547,892 | 471.47M |
| 347 | REPL | Replimune Group, Inc. | 1.22B | -2.42% | 4,085,048 | - |
| 348 | MNKD | MannKind Corporation | 1.21B | -1.06% | 2,469,876 | 393.63M |
| 349 | IART | Integra LifeSciences Holdings Corporation | 1.21B | -0.26% | 792,028 | 1.65B |
| 350 | OMDA | Omada Health, Inc. | 1.20B | -8.56% | 1,647,695 | 309.76M |
| 351 | IMTX | Immatics N.V. | 1.20B | 0.46% | 527,249 | 47.65M |
| 352 | GLUE | Monte Rosa Therapeutics, Inc. | 1.20B | -1.75% | 1,173,907 | 28.73M |
| 353 | TNDM | Tandem Diabetes Care, Inc. | 1.19B | -6.55% | 1,789,050 | 1.04B |
| 354 | ALMS | Alumis Inc. | 1.19B | -7.27% | 3,434,333 | 7.40M |
| 355 | ODTX | Odyssey Therapeutics, Inc. | 1.18B | 4.19% | 198,384 | 99.00K |
| 356 | SLBT | SL Science Holding Limited | 1.17B | -1.90% | 44,438 | 3.27M |
| 357 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 1.30% | 184,722 | 804.27M |
| 358 | OPK | OPKO Health, Inc. | 1.17B | 5.37% | 5,180,777 | 587.90M |
| 359 | PRCT | PROCEPT BioRobotics Corporation | 1.17B | 1.54% | 1,573,245 | 337.34M |
| 360 | GDRX | GoodRx Holdings, Inc. | 1.16B | 1.19% | 491,920 | 785.23M |
| 361 | CERT | Certara, Inc. | 1.15B | 1.75% | 1,487,180 | 421.75M |
| 362 | CRON | Cronos Group Inc. | 1.15B | -0.63% | 710,828 | 179.09M |
| 363 | JBIO | Jade Biosciences, Inc. | 1.14B | -6.53% | 1,249,196 | - |
| 364 | STAA | STAAR Surgical Company | 1.14B | -3.25% | 838,688 | 339.59M |
| 365 | TDOC | Teladoc Health, Inc. | 1.12B | 1.15% | 2,566,157 | 2.49B |
| 366 | ENOV | Enovis Corporation | 1.11B | 4.73% | 2,886,526 | 2.30B |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 1.10B | 2.68% | 545,711 | 1.04B |
| 368 | OBX | Obsidian Therapeutics, Inc. | 1.10B | 3.73% | 392,800 | - |
| 369 | APMD | Apnimed, Inc. | 1.09B | -2.13% | 207,776 | 115.12M |
| 370 | BVS | Bioventus Inc. | 1.09B | -0.61% | 421,806 | 581.85M |
| 371 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | -0.23% | 1,257,579 | - |
| 372 | MLTX | MoonLake Immunotherapeutics | 1.06B | -5.08% | 2,387,189 | - |
| 373 | IRMD | IRADIMED CORPORATION | 1.05B | 0.43% | 285,626 | 86.34M |
| 374 | JANX | Janux Therapeutics, Inc. | 1.05B | -3.28% | 791,602 | 24.00M |
| 375 | ATTO | Attovia Therapeutics, Inc. | 1.04B | 1.15% | 175,770 | 1.80M |
| 376 | KURA | Kura Oncology, Inc. | 1.01B | -1.56% | 2,117,529 | 77.23M |
| 377 | ABUS | Arbutus Biopharma Corporation | 1.01B | - | 1,850,050 | 181.72M |
| 378 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.01B | 1.02% | 410,954 | 730.02M |
| 379 | PCRX | Pacira BioSciences, Inc. | 1.01B | 0.79% | 538,041 | 746.16M |
| 380 | GMRS | GMR Solutions Inc. | 993.28M | 2.49% | 634,900 | 5.88B |
| 381 | CSTL | Castle Biosciences, Inc. | 987.67M | 0.03% | 224,204 | 357.28M |
| 382 | ANL | Adlai Nortye Group Ltd. | 979.49M | 0.80% | 228,744 | 18.06M |
| 383 | FTH | Faeth Therapeutics, Inc. | 967.47M | -4.00% | 377,120 | - |
| 384 | HELP | Cybin Inc. | 947.59M | 1.01% | 1,150,126 | - |
| 385 | SANA | Sana Biotechnology, Inc. | 937.00M | 1.29% | 3,280,174 | - |
| 386 | SLDB | Solid Biosciences Inc. | 932.86M | -4.08% | 1,113,858 | - |
| 387 | IVA | Inventiva S.A. | 932.40M | -2.90% | 1,713,181 | 7.94M |
| 388 | SGP | SpyGlass Pharma, Inc. | 920.49M | 0.77% | 169,468 | - |
| 389 | DSGN | Design Therapeutics, Inc. | 915.57M | -1.15% | 715,239 | - |
| 390 | CBLL | CeriBell, Inc. | 906.87M | 0.85% | 255,080 | 101.96M |
| 391 | WVE | Wave Life Sciences, Inc. | 904.45M | -1.71% | 2,208,381 | 65.37M |
| 392 | OLMA | Olema Pharmaceuticals, Inc. | 894.23M | -4.40% | 1,013,489 | - |
| 393 | ARDX | Ardelyx, Inc. | 892.09M | -1.10% | 5,690,264 | 450.89M |
| 394 | LXRX | Lexicon Pharmaceuticals, Inc. | 889.91M | -0.99% | 3,726,760 | 41.47M |
| 395 | TBPH | Theravance Biopharma, Inc. | 883.14M | -0.06% | 426,795 | 104.31M |
| 396 | RIGL | Rigel Pharmaceuticals, Inc. | 882.44M | -0.08% | 187,183 | 276.79M |
| 397 | IMMX | Immix Biopharma, Inc. | 868.49M | -4.41% | 1,190,507 | - |
| 398 | GERN | Geron Corporation | 867.34M | -1.46% | 9,867,667 | 204.56M |
| 399 | AVTX | Avalo Therapeutics, Inc. | 864.52M | -6.17% | 2,525,470 | 59.00K |
| 400 | INMD | InMode Ltd. | 856.46M | 0.88% | 450,769 | 374.63M |
| 401 | HSTM | HealthStream, Inc. | 851.18M | 0.80% | 150,164 | 321.12M |
| 402 | CBIO | Crescent Biopharma, Inc. | 830.77M | -0.26% | 264,449 | 11.88M |
| 403 | SIBN | SI-BONE, Inc. | 823.77M | 0.44% | 590,906 | 213.60M |
| 404 | CLYM | Climb Bio, Inc. | 818.47M | -4.68% | 1,378,432 | - |
| 405 | AVR | Anteris Technologies Global Corp. | 813.78M | 0.60% | 640,398 | 2.24M |
| 406 | AHCO | AdaptHealth Corp. | 808.46M | 3.59% | 2,082,099 | 3.36B |
| 407 | QDEL | QuidelOrtho Corporation | 807.82M | -3.05% | 1,067,986 | 2.67B |
| 408 | CADL | Candel Therapeutics, Inc. | 806.89M | -6.93% | 3,596,202 | - |
| 409 | SLN | Silence Therapeutics plc | 783.93M | -2.18% | 685,914 | 615.00K |
| 410 | ACRS | Aclaris Therapeutics, Inc. | 783.10M | -3.45% | 3,278,158 | 8.22M |
| 411 | NVCT | Nuvectis Pharma, Inc. | 781.63M | 6.67% | 221,084 | - |
| 412 | VREX | Varex Imaging Corporation | 778.05M | -0.05% | 1,029,461 | 865.00M |
| 413 | PHAR | Pharming Group N.V. | 761.51M | 3.70% | 39,069 | 366.48M |
| 414 | GLAS | Glass House Brands Inc. | 747.34M | -0.63% | 859,751 | 176.98M |
| 415 | ANNX | Annexon, Inc. | 746.94M | -4.83% | 3,939,352 | - |
| 416 | BBNX | Beta Bionics, Inc. | 745.48M | -0.12% | 726,147 | 119.01M |
| 417 | COLL | Collegium Pharmaceutical, Inc. | 740.64M | -0.74% | 661,301 | 808.21M |
| 418 | MNPR | Monopar Therapeutics Inc. | 740.08M | 0.27% | 90,262 | - |
| 419 | FDMT | 4D Molecular Therapeutics, Inc. | 727.57M | -2.37% | 481,190 | 92.01M |
| 420 | ACHV | Achieve Life Sciences, Inc. | 726.49M | -3.02% | 1,461,951 | - |
| 421 | AURA | Aura Biosciences, Inc. | 725.42M | 0.07% | 830,854 | - |
| 422 | MPLT | MapLight Therapeutics, Inc. | 722.48M | -5.73% | 340,166 | - |
| 423 | DBVT | DBV Technologies S.A. | 720.55M | -8.64% | 2,699,412 | 5.04M |
| 424 | AHG | Akso Health Group | 718.95M | 14.93% | 13,313 | 13.83M |
| 425 | CTMX | CytomX Therapeutics, Inc. | 716.89M | -1.79% | 2,249,984 | 18.30M |
| 426 | GYRE | Gyre Therapeutics, Inc. | 713.61M | -0.15% | 69,803 | 109.82M |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 713.20M | -0.41% | 583,005 | 136.07M |
| 428 | NGNE | Neurogene Inc. | 710.00M | -1.77% | 181,389 | 925.00K |
| 429 | SGMT | Sagimet Biosciences Inc. | 676.29M | -1.63% | 639,393 | - |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 674.18M | 2.77% | 1,249,560 | 389.32M |
| 431 | SOPH | SOPHiA GENETICS SA | 669.96M | 3.42% | 243,546 | 86.17M |
| 432 | MDXG | MiMedx Group, Inc. | 666.13M | -0.65% | 995,845 | 355.17M |
| 433 | PHAT | Phathom Pharmaceuticals, Inc. | 664.04M | -0.12% | 1,389,081 | 239.66M |
| 434 | SSII | SS Innovations International, Inc. | 663.28M | 0.30% | 85,121 | 52.40M |
| 435 | VSTM | Verastem, Inc. | 662.92M | -3.94% | 1,913,863 | 87.53M |
| 436 | OCS | Oculis Holding AG | 651.89M | -6.63% | 226,617 | 1.45M |
| 437 | AGMB | AgomAb Therapeutics NV | 643.18M | -6.31% | 196,653 | - |
| 438 | PHR | Phreesia, Inc. | 639.95M | 1.38% | 526,879 | 507.79M |
| 439 | BLSM | BlossomHill Therapeutics, Inc. | 639.23M | -3.02% | 148,975 | - |
| 440 | ALT | Altimmune, Inc. | 636.07M | -0.61% | 2,704,722 | 31.00K |
| 441 | VALN | Valneva SE | 635.68M | -0.45% | 36,611 | 163.30M |
| 442 | ANGO | AngioDynamics, Inc. | 631.15M | 0.20% | 341,962 | 320.17M |
| 443 | STLN | Starling Oncology, Inc. | 628.82M | -0.48% | 790,888 | 587.24M |
| 444 | DRUG | Bright Minds Biosciences Inc. | 628.56M | -2.80% | 129,222 | - |
| 445 | STTK | Shattuck Labs, Inc. | 622.25M | 0.81% | 846,934 | 1.00M |
| 446 | ALLO | Allogene Therapeutics, Inc. | 614.97M | 1.14% | 3,894,350 | 4.64M |
| 447 | EVO | Evotec SE | 612.30M | -2.26% | 42,524 | 819.47M |
| 448 | CRMD | CorMedix Inc. | 609.91M | -1.70% | 820,993 | 462.25M |
| 449 | CTEV | Claritev Corporation | 609.77M | -2.07% | 153,678 | 994.67M |
| 450 | ASMB | Assembly Biosciences, Inc. | 606.75M | -2.17% | 258,946 | 74.85M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 599.95M | -4.21% | 4,159,293 | 54.09M |
| 452 | CTKB | Cytek Biosciences, Inc. | 599.22M | 1.77% | 897,709 | 206.71M |
| 453 | OABI | OmniAb, Inc. | 591.74M | 3.04% | 1,315,828 | 38.46M |
| 454 | WEAV | Weave Communications, Inc. | 584.79M | 0.14% | 1,174,707 | 257.79M |
| 455 | KIDS | OrthoPediatrics Corp. | 575.98M | 2.32% | 239,520 | 252.72M |
| 456 | TECX | Tectonic Therapeutic, Inc. | 567.91M | 1.54% | 154,980 | - |
| 457 | RGNX | REGENXBIO Inc. | 563.09M | -0.35% | 1,029,134 | 174.48M |
| 458 | SCTX | Scribe Therapeutics Inc. | 563.03M | 0.92% | 141,195 | 33.30M |
| 459 | FLGT | Fulgent Genetics, Inc. | 562.69M | 1.64% | 380,509 | 323.93M |
| 460 | BWAY | BrainsWay Ltd. | 562.17M | 0.14% | 68,033 | 60.70M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 557.55M | 1.09% | 165,143 | - |
| 462 | PRME | Prime Medicine, Inc. | 556.84M | -6.57% | 3,077,071 | 4.07M |
| 463 | EPRX | Eupraxia Pharmaceuticals Inc. | 555.37M | 4.99% | 492,925 | - |
| 464 | ARVN | Arvinas, Inc. | 552.51M | -2.99% | 908,559 | 316.70M |
| 465 | DCTH | Delcath Systems, Inc. | 552.06M | 0.70% | 347,059 | 95.42M |
| 466 | TLRY | Tilray Brands, Inc. | 550.71M | -2.90% | 3,995,750 | 915.45M |
| 467 | PROK | ProKidney Corp. | 544.18M | -2.17% | 1,072,322 | 818.00K |
| 468 | OVID | Ovid Therapeutics Inc. | 525.35M | 2.28% | 1,147,533 | 1.58M |
| 469 | EOLS | Evolus, Inc. | 517.84M | -0.88% | 586,592 | 316.49M |
| 470 | TCMD | Tactile Systems Technology, Inc. | 507.41M | 0.36% | 240,359 | 350.31M |
| 471 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 472 | IRD | Opus Genetics, Inc. | 502.50M | -0.49% | 4,658,019 | 9.86M |
| 473 | CERS | Cerus Corporation | 501.80M | 1.22% | 1,545,741 | 221.55M |
| 474 | AUTL | Autolus Therapeutics plc | 500.39M | -4.08% | 1,724,835 | 117.39M |
| 475 | ARTV | Artiva Biotherapeutics, Inc. | 499.66M | -1.92% | 228,438 | 251.00K |
| 476 | ZURA | Zura Bio Limited | 499.27M | -3.16% | 1,421,307 | - |
| 477 | ENTX | Entera Bio Ltd. | 491.72M | 1.79% | 187,608 | 42.00K |
| 478 | CAPR | Capricor Therapeutics, Inc. | 486.62M | 0.84% | 2,074,937 | 11.13M |
| 479 | EIKN | Eikon Therapeutics, Inc. | 484.24M | -2.93% | 1,010,239 | - |
| 480 | RLMD | Relmada Therapeutics, Inc. | 482.15M | 11.06% | 2,629,280 | - |
| 481 | NPCE | NeuroPace, Inc. | 481.91M | 1.23% | 107,482 | 106.99M |
| 482 | EVH | Evolent Health, Inc. | 473.72M | 0.48% | 1,697,221 | 2.10B |
| 483 | SPRY | ARS Pharmaceuticals, Inc. | 473.37M | -5.93% | 2,573,537 | 116.93M |
| 484 | PRLD | Prelude Therapeutics Incorporated | 472.75M | -1.71% | 520,540 | 22.42M |
| 485 | PBYI | Puma Biotechnology, Inc. | 470.78M | -0.55% | 305,140 | 231.24M |
| 486 | NRC | NRC Health | 467.17M | -0.66% | 94,308 | 140.00M |
| 487 | KMDA | Kamada Ltd. | 464.97M | -0.88% | 106,644 | 191.85M |
| 488 | CABA | Cabaletta Bio, Inc. | 462.86M | -0.36% | 7,437,306 | - |
| 489 | SENS | Senseonics Holdings, Inc. | 460.53M | -0.91% | 395,169 | 48.55M |
| 490 | SRTA | Strata Critical Medical, Inc. | 459.59M | 1.27% | 770,733 | 255.98M |
| 491 | PRTA | Prothena Corporation plc | 458.44M | -1.00% | 376,276 | 54.53M |
| 492 | VOGX | Vogenx, Inc. | 455.24M | 9.54% | 98,316 | - |
| 493 | DNA | Ginkgo Bioworks Holdings, Inc. | 454.55M | -0.44% | 932,656 | 132.42M |
| 494 | KYTX | Kyverna Therapeutics, Inc. | 448.98M | -1.22% | 751,625 | - |
| 495 | SGHT | Sight Sciences, Inc. | 448.42M | 1.62% | 179,559 | 83.38M |
| 496 | RZLT | Rezolute, Inc. | 440.85M | 1.20% | 1,352,742 | - |
| 497 | CCCC | C4 Therapeutics, Inc. | 431.82M | 3.24% | 1,482,304 | 35.04M |
| 498 | IKT | Inhibikase Therapeutics, Inc. | 426.06M | 0.43% | 303,243 | 1.00 |
| 499 | AVIR | Atea Pharmaceuticals, Inc. | 425.89M | 2.51% | 489,582 | - |
| 500 | BNTC | Benitec Biopharma Inc. | 418.78M | -0.25% | 88,587 | - |